PEGFILGRASTIM-BMEZ: 399 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
399
Total FAERS Reports
144 (36.1%)
Deaths Reported
117
Hospitalizations
399
As Primary/Secondary Suspect
3
Life-Threatening
1
Disabilities
Prescription
Status
FDA Application: 761045 ·
First Report: 20180101 · Latest Report: 20250813
What Are the Most Common PEGFILGRASTIM-BMEZ Side Effects?
#1 Most Reported
Death
121 reports (30.3%)
#2 Most Reported
Drug ineffective
35 reports (8.8%)
#3 Most Reported
Neutropenia
34 reports (8.5%)
All PEGFILGRASTIM-BMEZ Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 121 | 30.3% | 121 | 2 |
| Drug ineffective | 35 | 8.8% | 4 | 15 |
| Neutropenia | 34 | 8.5% | 4 | 25 |
| Pyrexia | 23 | 5.8% | 0 | 12 |
| Febrile neutropenia | 17 | 4.3% | 1 | 13 |
| Malaise | 17 | 4.3% | 0 | 2 |
| Neoplasm malignant | 16 | 4.0% | 8 | 2 |
| Stenotrophomonas infection | 16 | 4.0% | 0 | 16 |
| Off label use | 15 | 3.8% | 0 | 11 |
| Leukopenia | 13 | 3.3% | 0 | 4 |
| Hospitalisation | 12 | 3.0% | 2 | 11 |
| Illness | 10 | 2.5% | 2 | 1 |
| Drug reaction with eosinophilia and systemic symptoms | 9 | 2.3% | 0 | 8 |
| Thrombocytopenia | 9 | 2.3% | 0 | 5 |
| Febrile bone marrow aplasia | 8 | 2.0% | 0 | 5 |
| Pulmonary embolism | 7 | 1.8% | 0 | 6 |
| Bone pain | 6 | 1.5% | 0 | 3 |
| Fatigue | 6 | 1.5% | 0 | 0 |
| Nausea | 6 | 1.5% | 0 | 2 |
| Needle issue | 6 | 1.5% | 0 | 1 |
Who Reports PEGFILGRASTIM-BMEZ Side Effects? Age & Gender Data
Gender: 55.8% female, 44.2% male. Average age: 57.3 years. Most reports from: US. View detailed demographics →
Is PEGFILGRASTIM-BMEZ Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2018 | 1 | 0 | 0 |
| 2019 | 9 | 2 | 6 |
| 2020 | 19 | 2 | 12 |
| 2021 | 18 | 8 | 5 |
| 2022 | 26 | 13 | 6 |
| 2023 | 48 | 12 | 29 |
| 2024 | 26 | 7 | 14 |
| 2025 | 29 | 7 | 14 |
What Is PEGFILGRASTIM-BMEZ Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 206 |
| Neutropenia | 30 |
| Prophylaxis | 17 |
| Blood disorder prophylaxis | 10 |
| Agranulocytosis | 7 |
| Colony stimulating factor therapy | 6 |
| Breast cancer | 5 |
| Chemotherapy | 5 |
| Febrile neutropenia | 5 |
| Hodgkin's disease | 5 |
PEGFILGRASTIM-BMEZ vs Alternatives: Which Is Safer?
PEGFILGRASTIM-BMEZ vs PEGFILGRASTIM-CBQV
PEGFILGRASTIM-BMEZ vs PEGFILGRASTIM-JMDB
PEGFILGRASTIM-BMEZ vs PEGINTERFERON ALFA
PEGFILGRASTIM-BMEZ vs PEGINTERFERON ALFA-2A
PEGFILGRASTIM-BMEZ vs PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B
PEGFILGRASTIM-BMEZ vs PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B OR PEGINTERFERON BETA-1A OR PEGINTERFERON LAMBDA-1A
PEGFILGRASTIM-BMEZ vs PEGINTERFERON ALFA-2B
PEGFILGRASTIM-BMEZ vs PEGINTERFERON BETA-1A
PEGFILGRASTIM-BMEZ vs PEGINTRON
PEGFILGRASTIM-BMEZ vs PEGLOTICASE
Official FDA Label for PEGFILGRASTIM-BMEZ
Official prescribing information from the FDA-approved drug label.